| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Compound 1541A | CTRPv2 | pan-cancer | AAC | 0.16 | 2e-05 |
| mRNA | Doxorubicin | gCSI | pan-cancer | AAC | -0.19 | 0.0002 |
| mRNA | ISOX | CTRPv2 | pan-cancer | AAC | 0.11 | 0.0003 |
| mRNA | Gemcitabine | gCSI | pan-cancer | AAC | -0.2 | 0.0004 |
| mRNA | PX-12 | CTRPv2 | pan-cancer | AAC | 0.098 | 0.0004 |
| mRNA | RG-108 | CTRPv2 | pan-cancer | AAC | 0.11 | 0.001 |
| mRNA | BRD-K88742110 | CTRPv2 | pan-cancer | AAC | 0.11 | 0.001 |
| mRNA | WZ3105 | GDSC1000 | pan-cancer | AAC | 0.088 | 0.002 |
| mRNA | ATRA | CTRPv2 | pan-cancer | AAC | 0.1 | 0.003 |
| mRNA | AGK-2 | CTRPv2 | pan-cancer | AAC | 0.11 | 0.003 |